Compound details
Xanthine
| Compound ID | CDAMM00032 |
|---|---|
| Common name | Xanthine | IUPAC name | 3,7-dihydropurine-2,6-dione |
| Molecular formula | C5H4N4O2 |
| Retention time | 9.11 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 153.041 | Theoretical mz | 153.041 |
| Error | 0.65 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.3668 |
| Inchi key | LRFVTYWOQMYALW-UHFFFAOYSA-N |
|---|---|
| Smiles | C1=NC2=C(N1)C(=O)NC(=O)N2 |
| Superclass | Organoheterocyclic compounds |
| Class | Imidazopyrimidines |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y2T3 | GDA | Guanine deaminase | T92460 | SEA |
| P00491 | PNP | Purine nucleoside phosphorylase | T78198 | SEA |
| P19971 | TYMP | Thymidine phosphorylase | T59929 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| Q12882 | DPYD | Dihydropyrimidine dehydrogenase | T75890 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T78198 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P00491 | PNP |
| T78198 | DI0167 | Gout | [ICD-11: FA25] | P00491 | PNP |
| T78198 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P00491 | PNP |
| T78198 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P00491 | PNP |
| T78198 | DI0351 | Psoriasis | [ICD-11: EA90] | P00491 | PNP |
| T59929 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P19971 | TYMP |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T75890 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q12882 | DPYD |